Home Cart Sign in  
Chemical Structure| 502-65-8 Chemical Structure| 502-65-8

Structure of Lycopene
CAS No.: 502-65-8

Chemical Structure| 502-65-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lycopene is a red-colored carotenoid found in tomatoes and other red fruits and vegetables. Carotenoids are powerful antioxidants that efficiently quench singlet oxygen, may paly a role in prevention cancers, cardiovascular stress, and other diseases.

Synonyms: NSC 407322

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lycopene

CAS No. :502-65-8
Formula : C40H56
M.W : 536.87
SMILES Code : CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(C)/CCC=C(C)C
Synonyms :
NSC 407322
MDL No. :MFCD00017350
InChI Key :OAIJSZIZWZSQBC-GYZMGTAESA-N
Pubchem ID :446925

Safety of Lycopene

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NRK52E cells 10 μM 24 hours To investigate the ameliorative effect of lycopene on AAI-induced renal fibrosis, results showed that lycopene intervention promoted autophagosome formation, increased the number of autolysosomes, and promoted the conversion of autophagosomes to autolysosomes. Autophagy. 2024 May;20(5):1114-1133
HepG2 cells 50 μM LYC 8 hours To investigate the effects of LYC on hepatocyte support for neuronal function. Results showed that LYC enhanced hepatocyte support for neurons, including improved cell senescence, enhanced mitochondrial function, and increased axon length in co-cultured neurons. Redox Biol. 2024 Nov;77:103363
TM4 cells 1 μM 4 hours Lycopene alleviated MEHP-induced disruption of intercellular junctions in mouse Sertoli cells J Adv Res. 2023 Jul;49:115-126
GC-1 cells 1 μM 4 hours Lycopene alleviated MEHP-induced disruption of intercellular junctions in mouse Spermatogonia cells J Adv Res. 2023 Jul;49:115-126
NRK52E cells 5 μM and 10 μM 24 hours Lycopene activated the Nrf2 nuclear translocation and its downstream HO-1 and NQO1 antioxidant signaling pathways, inhibited ROS production by renal tubular epithelial cells, and alleviated mitochondrial damage. Redox Biol. 2022 Nov;57:102494

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Deoxynivalenol (DON)-induced intestinal oxidative damage model Intragastric administration 10 mg/kg BW Once daily for 11 days LYC significantly increased average daily feed intake (ADFI), average daily gain (ADG), and repaired intestinal injury and barrier dysfunction, as evident by increased trans-epithelial electrical resistance (TEER) and decreased diamine oxidase (DAO) activity, as well as up-regulated tight junction proteins (occludin, claudin-1) under DON exposure. Furthermore, LYC treatment stabilized the functions of intestinal epithelial cells (Lgr5, PCNA, MUC2, LYZ, and Villin) under DON exposure. Additionally, LYC alleviated DON-induced oxidative stress by reducing ROS and MDA accumulation and enhancing the activity of antioxidant enzymes (CAT, T-SOD, T-AOC, and GSH-Px), which was linked with the activation of Nrf2 signaling and degradation of Keap1 expression. Antioxidants (Basel). 2021 Sep 18;10(9):1493
Rats and mice No specific disease model used Oral 8 mg/kg Single dose To evaluate the pharmacokinetics and tissue distribution of lycopene-loaded microemulsion (LME), showing a significant enhancement in relative bioavailability (210.30%) and brain-targeting efficiency (DTI=3.45). Drug Deliv. 2019 Dec;26(1):1191-1205
C57BL/6 male mice AAI-induced renal fibrosis model Oral gavage 20 mg/kg/day Once daily for 28 days To investigate the ameliorative effect of lycopene on AAI-induced renal fibrosis, results showed that lycopene intervention improved renal function recovery and histopathological changes, and reduced collagen deposition. Autophagy. 2024 May;20(5):1114-1133
Female CD-1 mice Aging mouse model Oral 0.03% (w/w, mixed with normal chow diet) Once daily for 3 months To investigate the effects of LYC on age-related cognitive deficits. Results showed that after 3 months of LYC treatment, brain aging and age-related cognitive deficits were effectively managed. Additionally, LYC ameliorated neuronal degeneration, mitochondrial dysfunction, and synaptic damage, and promoted synaptic vesicle fusion in 18-month-old mice. Redox Biol. 2024 Nov;77:103363
ICR male mice DEHP-induced spermatogenic disorders model Gavage 5 mg/kg Once daily for four weeks Lycopene improved DEHP-induced changes in sperm parameters and fertilization ability J Adv Res. 2023 Jul;49:115-126
C57BL/6 male mice Aristolochic acid nephropathy model Intragastric administration 5 mg/kg/d and 20 mg/kg/d Once daily for 28 days Lycopene was able to activate the Nrf2 antioxidant signaling pathway to maintain the homeostasis of renal oxidative stress and ultimately attenuated renal inflammatory response and apoptosis. Redox Biol. 2022 Nov;57:102494

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.31mL

1.86mL

0.93mL

18.63mL

3.73mL

1.86mL

References

 

Historical Records

Categories